Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03030287 |
Title | A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer |
Recruitment | Completed |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | OncoMed Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Colorado, Anschutz Medical Campus | Aurora | Colorado | 80045 | United States | Details | |
H. Lee Moffitt Cancer Center & Research Institute, Inc. (Moffitt Cancer Center) | Tampa | Florida | 33612 | United States | Details | |
Levine Cancer Institute | Charlotte | North Carolina | 28204 | United States | Details | |
Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
The University of Pennsylvania Health System | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | United States | Details | |
The University of Texas, MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |